Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
Abstract Aims Increasing attention is being given to patients with heart failure and ‘mid‐range’ left ventricular ejection fraction (LVEF, ≥40% and <50%) for whom there are no approved therapies that improve prognosis. We aim to assess for the first time the effects of cardiac contractility modul...
Main Authors: | Carsten Tschöpe, Javed Butler, Dimitrios Farmakis, Deborah Morley, Ishu Rao, Gerasimos Filippatos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13126 |
Similar Items
-
Plasma levels of free fatty acid differ in patients with left ventricular preserved, mid-range, and reduced ejection fraction
by: Ning Zhu, et al.
Published: (2018-05-01) -
Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction
by: Jun Shitara, et al.
Published: (2021-01-01) -
Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
by: M. A. Vander, et al.
Published: (2021-02-01) -
Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
by: Luca Branca, et al.
Published: (2020-04-01) -
Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)